PARSIPPANY, N.J., Nov. 1 /PRNewswire-FirstCall/ -- A mere three weeks
after their official launch, Triaminic(R) and Theraflu(R) Thin Strips(TM) have
been named "Best Product of 2004" by Convenience Industry News (CIN) magazine.
Thin Strips(TM), the first multi-symptom cough and cold medicines to deliver
an accurate dose in a thin film form, were selected from more than 100
applicants for their portability, convenience, and consumer acceptance.
The CIN judging panel, comprised of convenience-store industry
professionals, based its selection on the five factors of taste and quality
ingredients, packaging, consumer acceptance, innovation, differentiation, and
convenience. The winners were named at the recent National Association of
Convenience Stores Show in Las Vegas, Nevada.
Convenience Industry News' marketing director, Leila Khalil, commented,
"The competition for the first CIN Awards was incredibly strong and the
category of general merchandise 'Best Product of 2004' was one of the toughest
to judge. The diversity of products entered in this category, such as
batteries, cameras, mints, and air fresheners, meant that the judges had to
hone in on each product's unique attributes and compare them on their benefits
to consumers. Novartis' Thin Strips products impressed the judges with their
innovation. We believe the combination of thin film technology with active
medicine is certain to gain wide consumer acceptance and pave the way for
other medicines to move to this portable, exceptionally convenient form. In
turn, we expect that Thin Strips will help deliver excellent growth for the
convenience store category."
Growth in the over-the-counter cough/cold treatment category is
traditionally driven by new product innovation, with a 17.6 percent growth in
dollar sales in the 2002-2003 and 2003-2004 cough/cold seasons attributable to
new product launches(1). "Product innovation, such as Thin Strips, is
critical to the category and fuels growth by continuing to improve consumer
compliance and bringing new consumers to the category," continued Khalil. The
convenience store category is of significant importance to manufacturers, with
more than 100,000 stores across the US achieving gross sales of $290.6 billion
"Novartis Consumer Health, Inc. is delighted to be recognized and honored
by Convenience Industry News. With 40 years of "firsts" including hot
liquids, chewable tablets, vapor patches and now Thin Strips, the company has
made a firm commitment to delivering innovative self-medication treatments
that address consumers' demands for convenience. This commitment to product
development helps drive category growth while giving our retail partners the
products they need, when they need them," said Jeff Vernimb, vice president,
Marketing, Novartis Consumer Health, OTC.
Theraflu Thin Strips treat the most common symptoms of a cold in children
12 and older and adults and are available in two cherry-flavored treatment
options: Long Acting Cough that quiets coughs for up to eight hours, and
Multi-Symptom that, as well as quieting coughs, provides temporary relief from
a runny nose and sneezing, and soothes itchy, watery eyes and throat. Both
cost approximately $5.49 for a 12-strip pack. Triaminic Thin Strips, for
children ages 6-12, are available in two treatment options: Long Acting Cough
that quiets coughs for up to eight hours, in cherry flavor, and Cough & Runny
Nose, in grape flavor. They cost approximately $5.99 for a 16-strip pack.
The 'melts on the tongue' portable delivery mechanism is meant to be easy
to administer providing fast, accurate dosing that is expected to increase
compliance, particularly among children. There is no need for water or
measuring, and upon melting, the dose of medicine is swallowed, giving cold
sufferers convenient symptom relief while on the road to recovery at home, at
work, or on-the-go.
About Novartis Consumer Health, Inc.
The OTC Business Unit of Novartis Consumer Health, Inc., with headquarters
in Parsippany, New Jersey, is a world leader in the development, production
and marketing of self-medication products for the in-home treatment and
prevention of medical conditions and ailments and for the enhancement of
overall health and well being. The OTC Business Unit is part of Novartis AG
About Novartis AG
Novartis AG (NYSE: NVS) is a world leader in pharmaceuticals and consumer
health. In 2003, the Group's businesses achieved sales of USD 24.9 billion
and a net income of USD 5.0 billion. The Group invested approximately USD 3.8
billion in R&D. Headquartered in Basel, Switzerland, Novartis Group companies
employ about 78,500 people and operate in over 140 countries around the world.
For further information, please consult http://www.novartis.com.
About Convenience Industry News
Convenience Industry News (CIN) is a comprehensive news source for c-store
industry professionals wanting to be informed of the latest trends, innovative
marketing ideas, and the top news in every category of the petroleum and
convenience store sector. As the retailer's source for new ideas in marketing
and merchandising, CIN features product introductions in the core categories
of the industry and profiles top executives at the major chains and
corporations across the United States. CIN circulation is currently at 42,000
and growing, reaching a high number of independent retailers. CIN
communicates not only with all the corporate decision makers, but also with
the most difficult group to reach--operators who make the buying decisions at
the store level. Convenience Industry News is on track to reach its goal of
becoming the reference guide for the convenience store industry.
(1) IRI Data -- C/C Season, Oct -- Jan 2002-2004
(2) Convenience Industry News
SOURCE Novartis Consumer Health, Inc.